CASTLE BIOSCIENCES INC
Company Stats
- Market Cap
- $1.1B
- as of Sep 30, 2026
- Enterprise Value
- $978.9M
- Shares Outstanding
- 30.5M
- Free Float
- 95.7%
Income Statement
- Revenue
- $344.2M
- Operating Income
- -$42.8M
- Net Income
- -$24.2M
- EBITDA
- -$2.0M
- Revenue Growth, 3Y
- 35.9%
- FCF Margin, 3Y Avg
- 3.5%
- FCF Margin, Worst Year
- -8.8%
Cash Flow
- Free Cash Flow
- $28.3M
- FCF Yield
- 2.6%
- Owner FCF Yield
- -1.6%
Balance Sheet
- Cash & Equivalents
- $116.7M
- Total Debt
- $10.2M
- Net Cash
- $106.5M
Returns & Capital
- SBC, 3Y Avg
- $49.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $344.2M | $28.3M | 8.2% |
| FY2024 | $332.1M | $36.5M | 11.0% |
| FY2023 | $219.8M | -$19.2M | -8.8% |
| FY2022 | $137.0M | -$47.3M | -34.5% |
| FY2021 | $94.1M | -$22.5M | -23.9% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 30, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back